프로바이오틱스를 이용한 알레르기 질환 제어
Probiotics as an Immune Modulator for Allergic Disorders
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Allergic disorders such as atopic dermatitis and asthma are common hyperimmune disorders in industrialized countries. Although the exact etiology is unclear, several factors may trigger the disease onset. These include susceptible genetic background, environmental factors and an aberrant gut microbiota with a shift of the Th1/Th2 balance towards a Th2 response. Probiotics confer health benefits through multiple action mechanisms including modification of immune system in both systemic immune system and gut associated lymphoid tissue. Although many human clinical trials and mouse studies demonstrated the beneficial effects of probiotics in diverse allergic disorders, therapeutic efficacy is quite diverse depending on administration dose and types of strains or their mixture. To properly modulate allergic diseases, administration of tailor made probiotics with immune tolerance activity is required. Human clinical trials demonstrate a limited benefit of probiotics in atopic dermatitis in a preventive as well as a therapeutic capacity. In addition, beneficial effect of probiotics treatment is limited in the treatment of bronchial asthma. Identification of specific probiotics that has immune modulating activity and elucidation of the underlying mechanism of action will lead to develop probiotics as an as immune modulator targeting allergic disorders. Herein, we briefly review the diverse functions and regulation mechanisms of probiotics in allergic disorders including atopic dermatitis and asthma.
Abstract
Allergic disorders such as atopic dermatitis and asthma are common hyperimmune disorders in industrialized countries. Although the exact etiology is unclear, several factors may trigger the disease onset. These include susceptible genetic background, environmental factors and an aberrant gut microbiota with a shift of the Th1/Th2 balance towards a Th2 response. Probiotics confer health benefits through multiple action mechanisms including modification of immune system in both systemic immune system and gut associated lymphoid tissue. Although many human clinical trials and mouse studies demonstrated the beneficial effects of probiotics in diverse allergic disorders, therapeutic efficacy is quite diverse depending on administration dose and types of strains or their mixture. To properly modulate allergic diseases, administration of tailor made probiotics with immune tolerance activity is required. Human clinical trials demonstrate a limited benefit of probiotics in atopic dermatitis in a preventive as well as a therapeutic capacity. In addition, beneficial effect of probiotics treatment is limited in the treatment of bronchial asthma. Identification of specific probiotics that has immune modulating activity and elucidation of the underlying mechanism of action will lead to develop probiotics as an as immune modulator targeting allergic disorders. Herein, we briefly review the diverse functions and regulation mechanisms of probiotics in allergic disorders including atopic dermatitis and asthma.
참고문헌 (43)
- Yazdanbakhsh M, "Allergy, parasites, and the hygiene hypothesis", Science, 296, pp.490~494 (2002)
- Michail S, "The role of probiotics in allergic diseases", Allergy Asthma Clin Immunol, 5, pp.5~ (2009)
- van der Aa LB, "Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence", Pediatr Allergy Immunol, 21(2), pp.355~367 (2010)
- Corthesy B, "Cross- talk between probiotic bacteria and the host immune system", J Nutr, 137(3), pp.781~790 (2007)
- Rimoldi M, "Monocyte-derived dendritic cells activated by bacteria or by bacteria- stimulated epithelial cells are functionally different", Blood, 106, pp.2818~2826 (2005)
- Macdonald TT, "Immunity, inflammation, and allergy in the gut", Science, 307, pp.1920~1925 (2005)
- Kelly D, "Commensal gut bacteria: mechanisms of immune modulation", Trends Immunol, 26, pp.326~333 (2005)
- Macpherson AJ, "IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms", Microbes Infect, 3, pp.1021~1035 (2001)
- Bandeira A, "Localization of gamma", delta T cells to the intestinal epithelium is independent of normal microbial colonization, 1990, pp.172, 239~244
- Ostman S, "Impaired regulatory T cell function in germ- free mice", Eur J Immunol, 36, pp.2336~2346 (2006)
- Sudo N, "The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction", J Immunol, 159, pp.1739~1745 (1997)
- Herias MV, "Immunomodulatory effects of Lactobacillus plantarum colonizing the intestine of gnotobiotic rats", Clin Exp Immunol, 116, pp.283~290 (1999)
- Ouwehand AC, "Prebiotics and other microbial substrates for gut functionality", Curr Opin Biotechnol, 16, pp.212~217 (2005)
- Rosenfeldt V, "Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis", J Pediatr, 145, pp.612~616 (2004)
- 박승용, "Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production", Cellular Immunology, 219(1), pp.22~27 (2002), Academic Press
- Fang H, "Modulation of humoral immune response through probiotic intake", FEMS Immunol Med Microbiol, 29, pp.47~52 (2000)
- Gill HS, "Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019", Am J Clin Nutr, 74, pp.833~839 (2001)
- Fink LN, "Human antigen-presenting cells respond differently to gut-derived probiotic bacteria but mediate similar strain-dependent NK and T cell activation", FEMS Immunol Med Microbiol, 51, pp.535~546 (2007)
- Young SL, "Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood", Clin Diagn Lab Immunol, 11, pp.686~690 (2004)
- Zeuthen LH, "Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram- negative bacteria", Clin Vaccine Immunol, 13, pp.365~375 (2006)
- Kwon HK, "Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders", Proc Natl Acad Sci U S A, 107, pp.2159~2164 (2010)
- Kupper TS, "Immune surveillance in the skin: mechanisms and clinical consequences", Nat Rev Immunol, 4, pp.211~222 (2004)
- Akdis CA, "Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology", American Academy of Allergy, Asthma and Immunology, J Allergy Clin Immunol, pp.2006, 118[DOI]
- Leung DY, "New concepts in the pathogenesis of atopic dermatitis", Curr Opin Immunol, 15, pp.634~638 (2003)
- Kalliomaki M, "Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing", J Allergy Clin Immunol, 107, pp.129~134 (2001)
- Penders J, "Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study", Gut, 56, pp.661~667 (2007)
- Kendler M, "Comparison of fecal microflora in children with atopic eczema", dermatitis syndrome according to IgE sensitization to food, 2006, pp.17, 141~147
- Ouwehand AC, "Antiallergic effects of probiotics", J Nutr, 137(3), pp.794~797 (2007)
- Kalliomaki M, "Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial", Lancet, 357, pp.1076~1079 (2001)
- Abrahamsson TR, "Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial", J Allergy Clin Immunol, 119, pp.1174~1180 (2007)
- Wickens K, "A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo- controlled trial", J Allergy Clin Immunol, 122, pp.788~794 (2008)
- Soh SE, "Probiotic supplementation in the first 6 months of life in at risk Asian infants--effects on eczema and atopic sensitization at the age of 1 year", Clin Exp Allergy, 39, pp.571~578 (2009)
- Kopp MV, "Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation", Pediatrics, 121, pp.850~856 (2008)
- Weston S, "Effects of probiotics on atopic dermatitis: a randomised controlled trial", Arch Dis Child, 90, pp.892~897 (2005)
- Viljanen M, "Probiotics in the treatment of atopic eczema", dermatitis syndrome in infants: a double-blind placebo- controlled trial, 2005, pp.60, 494~500
- Sistek D, "Is the effect of probiotics on atopic dermatitis confined to food sensitized children?", Clin Exp Allergy, 36, pp.629~633 (2006)
- Folster-Holst R, "Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis", Br J Dermatol, 155, pp.1256~1261 (2006)
- Chen YS, "Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis", Pediatr Pulmonol, 45, pp.1111~1120 (2010)
- Sawada J, "Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC", Nga mice, 2007, pp.37, 296~303
- Tanaka A, "Oral supplementation with Lactobacillus rhamnosus CGMCC 1.3724 prevents development of atopic dermatitis in NC", NgaTnd mice possibly by modulating local production of IFN-gamma, 2009, pp.18, 1022~1027
- Won TJ, "Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC", Nga mice, 2011, pp.110, 1195~1202
- Feleszko W, "Probiotic- induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma", Clin Exp Allergy, 37, pp.498~505 (2007)
- Blumer N, "Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring", Clin Exp Allergy, 37, pp.348~357 (2007)